Science News
Antibodies in breast milk “teach” a newborn’s gut immune system to respond appropriately to microbes and maintain intestinal balance without causing unnecessary inflammation.
At the 13th Probiotics, Prebiotics and New Foods Congress, Silvia Turroni (University of Bologna) shares insights from the session “The Microbiome and One Health,” which explored how the microbiota bridges…
Profiling the human gut microbiota at the subspecies level, rather than at the species- or strain-level, provides more reproducible insights into how specific bacteria influence health and disease.
Gut bacteria cooperate to convert the dietary antioxidant ergothioneine into a compound that supports energy production.
Download the instant book.
During the 2025 Probiotics, Prebiotics & New Food congress, it was presented the English edition of "Microbioma al femminile", a book dedicated to the intricate relationship between the microbiota and…
The findings of a recent study reveal a key strategy used by A. baumannii to colonize the gut and persist in it, highlighting a potential target for preventing its spread…
Targeting specific gut bacteria and their metabolites could offer new ways to prevent or treat cardiovascular disease linked to diet and gut health.
Gianfranco Grompone, scientific director at BioGaia, explored innovative strategies for developing next-generation probiotics, with a focus on Limosilactobacillus reuteri DSM 17938.
Emmanuel Perrin, Advanced Technology Ingredients Senior Director Danone, explores Danone’s vision for harnessing the microbiome to guide the next generation of nutrition solutions.
Maintaining healthy T cells is key to preserving gut health and preventing chronic inflammation that drives aging-related diseases.
By revealing that OTUD3 limits microbiota-driven STING activation, the findings of a new study offer insights into the disease mechanisms of ulcerative colitis and may pave the way to new…
Jan Knol, Senior Director Research & Innovation at Danone Nutricia Research, discusses about the present and the future of microbiome research.
For Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, the message is clear: how we feed and protect our microbiome determines the clinical outcome.
Engineered bacteria can be used in gut therapies, but maintaining control over their colonization and genetic stability remains challenging.
Probiotics protect against obesity and inflammation caused by high sugar intake, supporting their use as a preventive strategy for obesity-related diabetes.
Mahesh Desai, group leader of the Eco-Immunology and Microbiome team at the Luxembourg Institute of Health and adjunct associate professor at the University of Southern Denmark, discusses about his research…
Maternal oral microbiota plays a key role in influencing infant gut health and disease risk.
A recent study highlights formate as a potential target to boost cancer treatment.
Recent studies have identified various bacterial and fungal pathobionts in patients with CD and UC.
